DK125198B - Analogifremgangsmåde til fremstilling af terapeutisk virksomme acylaminofenolalkanoler. - Google Patents
Analogifremgangsmåde til fremstilling af terapeutisk virksomme acylaminofenolalkanoler.Info
- Publication number
- DK125198B DK125198B DK358267A DK358267A DK125198B DK 125198 B DK125198 B DK 125198B DK 358267 A DK358267 A DK 358267A DK 358267 A DK358267 A DK 358267A DK 125198 B DK125198 B DK 125198B
- Authority
- DK
- Denmark
- Prior art keywords
- acylaminophenol
- alkanols
- preparation
- therapeutically effective
- analogous process
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1966D0050562 DE1543522B2 (de) | 1966-07-14 | 1966-07-14 | Acylaminophenolalkanole, verfahren zu ihrer herstellung und diese acylaminophenolalkanole enthaltende pharmazeutische mittel |
| DED0053088 | 1967-05-16 | ||
| DED0053177 | 1967-05-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK125198B true DK125198B (da) | 1973-01-15 |
Family
ID=27209864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK358267A DK125198B (da) | 1966-07-14 | 1967-07-11 | Analogifremgangsmåde til fremstilling af terapeutisk virksomme acylaminofenolalkanoler. |
Country Status (7)
| Country | Link |
|---|---|
| AT (1) | AT273932B (xx) |
| CH (1) | CH523224A (xx) |
| DE (3) | DE1543522B2 (xx) |
| DK (1) | DK125198B (xx) |
| GB (1) | GB1137596A (xx) |
| NL (1) | NL6709789A (xx) |
| SE (1) | SE335541B (xx) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6210048A (ja) * | 1985-07-04 | 1987-01-19 | Microbial Chem Res Found | 新規生理活性物質ｍｈ４３５ |
-
1966
- 1966-07-14 DE DE1966D0050562 patent/DE1543522B2/de active Granted
-
1967
- 1967-05-16 DE DE19671593828 patent/DE1593828A1/de active Pending
- 1967-05-26 DE DE19671593834 patent/DE1593834A1/de active Pending
- 1967-06-12 CH CH829367A patent/CH523224A/de not_active IP Right Cessation
- 1967-06-16 AT AT560267A patent/AT273932B/de active
- 1967-06-22 SE SE904267A patent/SE335541B/xx unknown
- 1967-07-11 DK DK358267A patent/DK125198B/da unknown
- 1967-07-12 GB GB3211867A patent/GB1137596A/en not_active Expired
- 1967-07-14 NL NL6709789A patent/NL6709789A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE1593834A1 (de) | 1971-02-25 |
| GB1137596A (en) | 1968-12-27 |
| NL6709789A (xx) | 1968-01-15 |
| CH523224A (de) | 1972-05-31 |
| DE1593828A1 (de) | 1970-10-29 |
| AT273932B (de) | 1969-08-25 |
| DE1543522A1 (de) | 1969-09-04 |
| DE1543522B2 (de) | 1976-05-06 |
| SE335541B (xx) | 1971-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK128353B (da) | Analogifremgangsmåde til fremstilling af terapeutisk aktive bis-chromoner. | |
| DK133618B (da) | Analogifremgangsmåde til fremstilling af 1-hydroxyaryl-2-aminoalkanoler. | |
| DK117896B (da) | Analogifremgangsmåde til fremstilling af 17-estere af 21-desoxyprednisolon. | |
| DK113645B (da) | Fremgangsmåde til fremstilling af terapeutisk virksomme indolyl-3-alkan-carboxylsyrer. | |
| DK115400B (da) | Fremgangsmåde til fremstilling af terapeutisk virksomme 3-keto-19-alkyl-androstaner. | |
| DK121708B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme 22-aza-cholestanderivater. | |
| DK117635B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme 3-(piperazinoalkyl)-pyrazoler. | |
| DK136033B (da) | Fremgangsmåde til fremstilling af indolyl-3-eddikesyrer. | |
| DK124886B (da) | Fremgangsnmåde til fremstilling af 1-hydroxy-benzimidazol-N-oxider. | |
| DK117954B (da) | Fremgangsmåde til fremstilling af 3-amino-2-cyanoacrylamid. | |
| DK124943B (da) | Analogifremgangsmåde til fremstilling af substituerede phenylacetamider. | |
| DK122072B (da) | Fremgangsmåde til fremstilling af umættede esteralkoholer. | |
| DK121922B (da) | Fremgangsmåde til fremstilling af formede tabletter. | |
| DK116060B (da) | Fremgangsmåde til fremstilling af 1-methyl-5-nitroimidazolcarbamater. | |
| DK120399B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme phenylalaninderivater. | |
| DK115551B (da) | Fremgangsmåde til fremstilling af 6-aminouracil-5-carbonamid-N-sulfonamider. | |
| DK125198B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme acylaminofenolalkanoler. | |
| DK114063B (da) | Fremgangsmåde til fremstilling af 1-methyl-2-isopropyl-5-nitro-imidazol. | |
| DK120344B (da) | Fremgangsmåde til fremstilling af 5-benzyl-pyrimidiner. | |
| DK117488C (da) | Fremgangsmåde til fremstilling af terapeutisk aktive 2α-3α-epithio-5α-androstaner. | |
| DK122223B (da) | Analogifremgangsmåde til fremstilling af terapeutisk aktive biphenylforbindelser. | |
| DK126378B (da) | Analogifremgangsmåde til fremstilling af 17α-acyloxy-9α-chlor-11β-hydroxy-progesteroner. | |
| DK119830B (da) | Analogifremgangsmåde til fremstilling af arylsulfonylsemicarbazider. | |
| DK114626B (da) | Fremgangsmåde til fremstilling af 2-substitueret-4-amino-5-acylamidometylpyrimidin. | |
| DK115552B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme 3-amino-tetrahydroindazoler. |